Try
AGILENT TECHNOLOGIES, INC.
AUnited States
78 filed reports · 725 financial concepts · 2 earnings calls · 1 media appearances
Filed reports
78 reports · Jul 2016 to Jul 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 320 guidance figures, 23 commentary passages.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 37 | 327 | Jan 2017 to Jul 2026 |
| Quarterly · 10-QSEC EDGAR | 31 | 7,459 | Jul 2016 to Jul 2026 |
| Annual · 10-KSEC EDGAR | 10 | 7,884 | Oct 2016 to Oct 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 10-Q | Jul 31, 2026 | Sep 1, 2026 | 456 | Open |
| FY2026 Q3 | 8-K | Jul 31, 2026 | Aug 26, 2026 | 17 | Open |
| FY2026 Q2 | 10-Q | Apr 30, 2026 | Jun 1, 2026 | 339 | Open |
| FY2026 Q2 | 8-K | Apr 30, 2026 | May 27, 2026 | 10 | Open |
| FY2026 Q1 | 10-Q | Jan 31, 2026 | Mar 3, 2026 | 330 | Open |
| FY2026 Q1 | 8-K | Jan 31, 2026 | Feb 25, 2026 | 12 | Open |
| FY2025 | 10-K | Oct 31, 2025 | Dec 22, 2025 | 1,353 | Open |
| FY2025 Q4 | 8-K | Oct 31, 2025 | Nov 24, 2025 | 8 | Open |
| FY2025 Q3 | 10-Q | Jul 31, 2025 | Aug 29, 2025 | 230 | Open |
| FY2025 Q3 | 8-K | Jul 31, 2025 | Aug 27, 2025 | 8 | Open |
| FY2025 Q2 | 10-Q | Apr 30, 2025 | Jun 2, 2025 | 211 | Open |
| FY2025 Q2 | 8-K | Apr 30, 2025 | May 28, 2025 | 8 | Open |
Financial data
725 concepts · 15,670 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial685 concepts · 13,121 facts · Oct 2014 to Jul 2026
- Standard product warranty accrual58 · Oct 2014 to Jul 2026
- Accumulated other comprehensive income loss net of tax57 · Oct 2014 to Jul 2026
- Allocated share based compensation expense57 · Oct 2014 to Jul 2026
- Amortization of intangible assets57 · Oct 2014 to Jul 2026
- Cash and cash equivalents at carrying value57 · Jul 2015 to Jul 2026
- Costs and expenses57 · Oct 2014 to Jul 2026
- Impairment of intangible assets indefinitelived excluding goodwill57 · Oct 2014 to Jul 2026
- Income tax expense benefit57 · Oct 2014 to Jul 2026
- Incremental common shares attributable to share based payment arrangements57 · Oct 2014 to Jul 2026
- Interest expense (US GAAP)57 · Oct 2014 to Jul 2026
- Investment income interest57 · Oct 2014 to Jul 2026
- Operating income loss57 · Oct 2014 to Jul 2026
- Other comprehensive income defined benefit plans net unamortized gain loss arising during period net of tax57 · Oct 2014 to Jul 2026
- Other comprehensive income defined benefit plans net unamortized gain loss arising during period tax57 · Oct 2014 to Jul 2026
- Other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax57 · Oct 2014 to Jul 2026
- Other comprehensive income loss foreign currency translation adjustment tax57 · Oct 2014 to Jul 2026
- Other comprehensive income loss net of tax57 · Oct 2014 to Jul 2026
- Other nonoperating income expense57 · Oct 2014 to Jul 2026
- Payments of dividends common stock57 · Oct 2014 to Jul 2026
- Research and development expense57 · Oct 2014 to Jul 2026
- Revenue57 · Oct 2014 to Jul 2026
- Selling general and administrative expense57 · Oct 2014 to Jul 2026
- Deferred income tax expense benefit56 · Oct 2014 to Jul 2026
- Depreciation depletion and amortization56 · Oct 2014 to Jul 2026
Segment26 concepts · 1,749 facts · Oct 2014 to Jul 2026
- Revenue598 · Oct 2014 to Jul 2026
- Operating income loss225 · Oct 2014 to Jul 2026
- Total Assets161 · Oct 2015 to Jul 2025
- Goodwill155 · Oct 2015 to Apr 2026
- Goodwill acquired during period93 · Oct 2015 to Oct 2025
- Goodwill translation and purchase accounting adjustments90 · Jan 2017 to Jul 2026
- Depreciation70 · Oct 2014 to Jul 2026
- Allocated share based compensation expense40 · Oct 2021 to Jul 2026
- Share based compensation36 · Oct 2014 to Oct 2022
- Goodwill foreign currency translation gain loss35 · Oct 2015 to Oct 2025
- Operating Income32 · Jul 2015 to Jul 2023
- Payments to acquire property plant and equipment32 · Oct 2015 to Oct 2022
- Cost of goods and services sold (US GAAP)30 · Oct 2023 to Jul 2026
- Research and development expense30 · Oct 2023 to Jul 2026
- Selling general and administrative expense30 · Oct 2023 to Jul 2026
- Revenue (excluding assessed tax)24 · Jul 2017 to Apr 2023
- Goodwill transfers21 · Oct 2018 to Jan 2025
- Revenue from contracts with customers (excluding tax)12 · Oct 2016 to Apr 2018
- Segment expenditure addition to long lived assets9 · Oct 2022 to Oct 2024
- Capital Expenditures8 · Oct 2015 to Oct 2022
- Goodwill purchase accounting adjustments5 · Jan 2025 to Oct 2025
- Stock-Based Compensation5 · Oct 2015 to Oct 2022
- Goodwill written off related to sale of business unit3 · Oct 2023
- Indefinite lived intangible assets purchase accounting adjustments3 · Jul 2019 to Oct 2019
Guidance8 concepts · 327 facts · Feb 2017 to Aug 2026
- Revenue Guidance146 · Feb 2017 to Aug 2026
- EPS (Diluted) Guidance142 · Feb 2017 to May 2026
- Revenue Growth Guidance26 · Feb 2017 to Aug 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))4 · Aug 2026
- Revenue Growth Guidance (Adjusted (non-GAAP))4 · Aug 2026
- Free Cash Flow Guidance2 · Aug 2017
- Operating Margin Guidance2 · May 2026
- Operating Margin Guidance (Adjusted (non-GAAP))1 · Aug 2026
Product4 concepts · 311 facts · Oct 2014 to Jul 2026
- Revenue205 · Oct 2014 to Jul 2026
- Cost of goods and services sold (US GAAP)90 · Oct 2016 to Jul 2026
- Prior period reclassification adjustment12 · Oct 2016 to Oct 2017
- Cost of revenue (US GAAP)4 · Jul 2017 to Jul 2018
Geography2 concepts · 162 facts · Oct 2014 to Jul 2026
- Revenue156 · Oct 2014 to Jul 2026
- Cash and Equivalents6 · Oct 2020 to Oct 2025
Segments
2,222 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments16 members · 1,749 facts
- Agilent Cross Lab386 · Oct 2014 to Jul 2026
- Life Sciencesand Applied Markets302 · Oct 2014 to Oct 2024
- Diagnostics And Genomics294 · Oct 2014 to Oct 2024
- Applied Markets135 · Oct 2023 to Jul 2026
- Life Sciences And Diagnostics Markets135 · Oct 2023 to Jul 2026
- Segment Total109 · Oct 2014 to Jul 2023
- Agilent cross lab98 · Oct 2015 to Apr 2026
- Segment total90 · Jul 2015 to Jul 2023
- Diagnostics and genomics86 · Oct 2015 to Oct 2024
- Life sciencesand applied markets83 · Oct 2015 to Oct 2024
- Applied markets13 · Oct 2024 to Apr 2026
- Life sciences and diagnostics markets13 · Oct 2024 to Apr 2026
- Corporate and other2 · Oct 2022 to Jul 2023
- Assetimpairment1 · Oct 2014
- Diagnosticsandgenomicssolutions1 · Oct 2018
- NMR1 · Oct 2014
Product or servicesrt:ProductOrServiceAxis10 members · 287 facts
- Product94 · Oct 2016 to Jul 2026
- Service Other94 · Oct 2016 to Jul 2026
- Instrumentation41 · Oct 2016 to Jul 2026
- Non Instrumentationand Other38 · Jan 2019 to Jul 2026
- Servicesandothercostofsales4 · Oct 2016 to Oct 2017
- Servicesandotherrevenue4 · Oct 2016 to Oct 2017
- Analyticallabconsumables3 · Oct 2016 to Oct 2018
- Analytical Lab Services3 · Oct 2016 to Oct 2018
- Diagnosticsandgenomicssolutions3 · Oct 2016 to Oct 2018
- Informaticsandother3 · Oct 2016 to Oct 2018
Statement geographicalsrt:StatementGeographicalAxis7 members · 150 facts
- Americas38 · Jan 2019 to Jul 2026
- Asia Pacific38 · Jan 2019 to Jul 2026
- Europe38 · Jan 2019 to Jul 2026
- CN10 · Oct 2016 to Oct 2025
- Rest Of World10 · Oct 2016 to Oct 2025
- US10 · Oct 2016 to Oct 2025
- Non us6 · Oct 2020 to Oct 2025
Product or serviceus-gaap:ProductOrServiceAxis7 members · 24 facts
- Analyticallabconsumables4 · Oct 2014 to Oct 2017
- Analytical Lab Services4 · Oct 2014 to Oct 2017
- Diagnosticsandgenomicssolutions4 · Oct 2014 to Oct 2017
- Informaticsandother4 · Oct 2014 to Oct 2017
- Instrumentation4 · Oct 2014 to Oct 2017
- Servicesandothercostofsales2 · Jan 2017 to Apr 2017
- Servicesandotherrevenue2 · Jan 2017 to Apr 2017
Statement geographicalus-gaap:StatementGeographicalAxis3 members · 12 facts
- CN4 · Oct 2014 to Oct 2017
- Rest Of World4 · Oct 2014 to Oct 2017
- US4 · Oct 2014 to Oct 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary24 claims from 8 reports · Oct 2024 to Jul 2026
- Management discussion (MD&A) commentary185 claims from 8 reports · Oct 2024 to Jul 2026
- Risk-factor changes4 claims from 1 reports · Oct 2025
- Risk factors69 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q3Aug 26, 2026
- FY2026 Q2May 27, 2026
Executive media
1 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- TV interviews1 · Dec 2024
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.